How do cancers become resistant to chemotherapy?

April 3, 2012, Public Library of Science

Genetic mutations in cancer cells can lead to resistance to treatment, thereby potentially resulting in relapse. However, a new article, published April 3 in the magazine section of the online, open-access journal PLoS Biology, suggests that the converse may also happen. Steven Frank from the University of California, Irvine, and Marsha Rosner from the University of Chicago, propose that it may often be the case that a few cells become resistant before any genetic change, and then later acquire the genes to stabilize that resistance.

Why does it matter whether resistance comes before , or vice versa? Because the effectiveness of treatment depends primarily on preventing resistance. If, as is the current view, genetic mutations occur first and then spread to cause resistance, then treatment protocols must focus on preventing the origination of with the particular set of mutations that cause this resistance. Widely used combination therapies are designed specifically to limit the chance that a cancer cell can develop the suite of mutations necessary for resistance.

Frank and Rosner argue that a few cells may often become resistant before they get specific genetic mutations. Such non-genetic resistance may occur through the random variation in cellular characteristics that has been widely observed among genetically identical cells. Alternatively, non-genetic resistance may occur when cells change (essentially reprogram) their characteristics in response to the stress of moving into new tissues, or dealing with . Cells are known to have many flexible programs of expression in response to a change in their environment. If cells first become resistant by either non-genetic randomness or flexibility, then those can later acquire genetic changes to stabilize their resistance. Such a progression that starts with non-genetic resistance necessarily alters one's ideas as to how to design combinations of drugs aimed at preventing relapse.

The idea that non-genetic resistance comes first is not entirely new. But the small amount of existing evidence has not led to a change in how people view the issue. This new article aims to bring this perspective to a wider group of researchers by combining the evidence from prior studies with a clear understanding of the evolutionary theory by which populations adapt to extreme challenges. New studies, designed in the light of how evolution might occur in cancers, will show whether alternative approaches to treatment can improve outcomes.

Explore further: Researchers develop new technology to screen and analyze genetic mutations

More information: Frank SA, Rosner MR (2012) Nonheritable Cellular Variability Accelerates the Evolutionary Processes of Cancer. PLoS Biol 10(4): e1001296. doi:10.1371/journal.pbio.1001296

Related Stories

Researchers develop new technology to screen and analyze genetic mutations

April 7, 2011
A single change to even one of the thousands of DNA codes that make up each gene in the human genome can result in severe diseases such as cancer, cystic fibrosis, muscular dystrophy or Huntington's Disease. A similarly minor ...

Research provides insight into new drug resistance in hospital microbes

July 13, 2011
Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to ...

Recommended for you

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

nanotech_republika_pl
not rated yet Apr 04, 2012
"Such non-genetic resistance may occur through the random variation in cellular characteristics that has been widely observed among genetically identical cells."

Huh? Like what variation in cellular characterists? Thru epigenetics, right?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.